WealthCollab’s Organon & Co OGN Stock Holding History

WealthCollab’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Buy	798 +793	+15,860%	+$9.48K	﹤0.01%	560
2026 Q1	$30	Hold	5	–	–	﹤0.01%	975
2025 Q4	$36	Sell	5 -929	-99%	-$7.34K	﹤0.01%	1019
2025 Q3	$9.98K	Buy	934 +331	+55%	+$3.25K	﹤0.01%	525
2025 Q2	$5.84K	Sell	603 -463	-43%	-$4.78K	﹤0.01%	603
2025 Q1	$15.9K	Buy	1,066 +128	+14%	+$1.97K	0.01%	369
2024 Q4	$14K	Buy	938 +78	+9%	+$1.27K	0.01%	390
2024 Q3	$16.5K	Buy	860 +69	+9%	+$1.43K	0.01%	360
2024 Q2	$16.4K	Hold	791	–	–	0.01%	329
2024 Q1	$14.9K	Sell	791 -286	-27%	-$4.91K	0.01%	346
2023 Q4	$15.5K	Buy	+1,077	New	+$14.7K	0.01%	318

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

WealthCollab's OGN Position: Q2 2026 in Review

WealthCollab increased its Organon & Co (OGN) stake by 15,860% in Q2 2026, buying an estimated $9.48K and bringing the position to 798 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

WealthCollab first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $16.5K in Q3 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

WealthCollab held 798 shares of Organon & Co worth $10.8K as of Q2 2026.
WealthCollab bought 793 Organon & Co shares in Q2 2026, an estimated $9.48K.
Organon & Co made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #560 holding.
WealthCollab first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
WealthCollab's Organon & Co position peaked at $16.5K in Q3 2024.
635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.